Edition:
United Kingdom

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

1.65USD
20 Feb 2018
Change (% chg)

$0.03 (+1.85%)
Prev Close
$1.62
Open
$1.76
Day's High
$1.76
Day's Low
$1.65
Volume
4,643
Avg. Vol
24,726
52-wk High
$4.15
52-wk Low
$1.35

Latest Key Developments (Source: Significant Developments)

Jack W. Schuler Living Trust Reports 13.4 Pct Stake In Soleno Therapeutics As Of December 15
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Soleno Therapeutics Inc ::JACK W. SCHULER LIVING TRUST REPORTS 13.4 PERCENT STAKE IN SOLENO THERAPEUTICS INC AS OF DECEMBER 15 - SEC FILING.  Full Article

Birchview Capital LP Reports A 6.17 Pct Passive Stake In Soleno Therapeutics
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Soleno Therapeutics Inc ::BIRCHVIEW CAPITAL LP REPORTS A 6.17 PCT PASSIVE STAKE IN SOLENO THERAPEUTICS AS OF DEC 15 - SEC FILING.  Full Article

Soleno Therapeutics Announces $15 Million Private Placement
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Soleno Therapeutics Inc ::SOLENO THERAPEUTICS ANNOUNCES $15 MILLION PRIVATE PLACEMENT.SOLENO THERAPEUTICS INC - SOLENO TO SELL 8.1 MILLION OF ITS COMMON SHARES AT $1.8425/SHARE.SOLENO THERAPEUTICS - TO USE PROCEEDS CONDUCT PLANNED PHASE III PROGRAM OF DIAZOXIDE CHOLINE CONTROLLED-RELEASE IN PRADER-WILLI SYNDROME.  Full Article

Soleno Therapeutics Announces Joint Venture Agreement For Commercialization Of Cosense Monitoring Technology
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Soleno Therapeutics Inc ::SOLENO THERAPEUTICS ANNOUNCES JOINT VENTURE AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF COSENSE MONITORING TECHNOLOGY.SOLENO THERAPEUTICS INC - UNDER TERMS OF JV AGREEMENT, OAHL WILL INVEST UP TO $2.2 MILLION IN TRANCHES TO PURCHASE SHARES OF OUR CAPNIA SUBSIDIARY.SOLENO THERAPEUTICS INC - CAPNIA WILL NO LONGER BE A WHOLLY-OWNED SUBSIDIARY OF SOLENO.SOLENO THERAPEUTICS INC - UNDER TERMS OF JV AGREEMENT, GOING FORWARD, OAHL WILL BE RESPONSIBLE FOR FUNDING OPERATIONS OF CAPNIA.  Full Article

Soleno Therapeutics posts Q3 loss $0.24/shr from continuing operations
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Soleno Therapeutics Inc :Soleno Therapeutics provides corporate update and reports third quarter 2017 financial results.Q3 loss per share $0.24 from continuing operations.Q3 loss per share $0.35.  Full Article

Capnia Q2 loss per share $0.23
Friday, 12 Aug 2016 

Capnia Inc : Q2 loss per share $0.23 .Capnia reports second quarter 2016 financial results.  Full Article

Capnia says distribution agreement for CoSense monitor in India
Tuesday, 7 Jun 2016 

Capnia Inc : Capnia announces exclusive distribution agreement for CoSense® End-Tidal Carbon Monoxide monitor in India . Under terms, Healthware will be responsible for all sales and related activities supporting distribution of CoSense in India .Sales of CoSense to Healthware will commence immediately.  Full Article

Capnia reports Q1 loss of $0.22 per share
Tuesday, 10 May 2016 

Capnia Inc : Says total revenue recognized in three months ended march 31, 2016 was $447,000 as compared to $22,000 in same period in 2015 . Capnia reports first quarter 2016 financial results .Q1 loss per share $0.22.  Full Article

BRIEF-Soleno Therapeutics Announces Successful End-Of-Phase II Meeting With FDA For DCCR In Prader-Willi Syndrome

* SOLENO THERAPEUTICS ANNOUNCES SUCCESSFUL END-OF-PHASE II MEETING WITH FDA FOR DCCR IN PRADER-WILLI SYNDROME